Clefting disorders
Gene: ERBB2
ERBB2 encodes HER2 an epidermal growth factor receptor. Gain of function of this gene (amplification/SNV/in frame dup) is known to have a significant role in cancer.
PMID 42060361 reports five families, 9 individuals with heterozygous ERBB2 missense variants presenting with poor growth/short stature, cleft lip/palate, and variable mild craniofacial malformations.
3 variants were de novo and 2 were inherited from affected family members.
A loss of function mechanism is proposed.
ERBB2 is not under loss of function constraint in gnomAD v4 (pLI 0.25). All but one variant reported in affected individuals were present in gnomAD v4 with 4-34 heterozygotes present.
Extensive supportive functional studies were performed including xenopus embryo knock in with rescue upon introduction of wild type, mouse knock in and HEK293 cell studies noting loss of downstream signalling.Created: 12 May 2026, 12:18 p.m.
Mode of inheritance
BOTH monoallelic and biallelic, autosomal or pseudoautosomal
Phenotypes
Syndromic disease, MONDO:0002254, ERBB2-related
Publications
gene: ERBB2 was added gene: ERBB2 was added to Clefting disorders. Sources: Expert Review Amber,Victorian Clinical Genetics Services Mode of inheritance for gene: ERBB2 was set to BOTH monoallelic and biallelic, autosomal or pseudoautosomal Publications for gene: ERBB2 were set to 40329538; 33720042 Phenotypes for gene: ERBB2 were set to Congenital heart disease - left ventricular outflow tract obstruction defects; MONDO:0005453; Hirschsprung disease (HSCR, aganglionic megacolon, MIM#142623)